FI913510A0 - Menetelmä terapeuttisesti käyttökelpoisten, raseemisten tai optisesti aktiivisten pyrido/1,2-a/pyratsiinien valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten, raseemisten tai optisesti aktiivisten pyrido/1,2-a/pyratsiinien valmistamiseksi

Info

Publication number
FI913510A0
FI913510A0 FI913510A FI913510A FI913510A0 FI 913510 A0 FI913510 A0 FI 913510A0 FI 913510 A FI913510 A FI 913510A FI 913510 A FI913510 A FI 913510A FI 913510 A0 FI913510 A0 FI 913510A0
Authority
FI
Finland
Prior art keywords
pyrazines
racemic
preparation
optically active
therapeutically useful
Prior art date
Application number
FI913510A
Other languages
English (en)
Swedish (sv)
Other versions
FI95381C (fi
FI95381B (fi
Inventor
Gene Michael Bright
Kishor Amratlal Desai
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI913510A0 publication Critical patent/FI913510A0/fi
Application granted granted Critical
Publication of FI95381B publication Critical patent/FI95381B/fi
Publication of FI95381C publication Critical patent/FI95381C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
FI913510A 1989-01-23 1991-07-22 Menetelmä terapeuttisesti käyttökelpoisten, raseemisten tai optisesti aktiivisten pyrido/1,2-a/pyratsiinien valmistamiseksi FI95381C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8900275 1989-01-23
PCT/US1989/000275 WO1990008148A1 (en) 1989-01-23 1989-01-23 Bis-aza-bicyclic anxiolytic agents
PCT/US1989/003811 WO1990008144A1 (en) 1989-01-23 1989-09-01 Bis-aza-bicyclic anxiolytic agents
US8903811 1989-09-01

Publications (3)

Publication Number Publication Date
FI913510A0 true FI913510A0 (fi) 1991-07-22
FI95381B FI95381B (fi) 1995-10-13
FI95381C FI95381C (fi) 1996-01-25

Family

ID=22214801

Family Applications (1)

Application Number Title Priority Date Filing Date
FI913510A FI95381C (fi) 1989-01-23 1991-07-22 Menetelmä terapeuttisesti käyttökelpoisten, raseemisten tai optisesti aktiivisten pyrido/1,2-a/pyratsiinien valmistamiseksi

Country Status (38)

Country Link
US (1) US5122525A (fi)
EP (1) EP0380217B1 (fi)
JP (1) JPH0643427B2 (fi)
KR (1) KR910009289B1 (fi)
CN (1) CN1022186C (fi)
AP (1) AP128A (fi)
AR (1) AR246969A1 (fi)
AT (1) ATE82574T1 (fi)
AU (1) AU614214B2 (fi)
BA (1) BA98302A (fi)
BG (1) BG51046A3 (fi)
CA (1) CA2008108C (fi)
CZ (1) CZ277698B6 (fi)
DD (1) DD291560A5 (fi)
DE (1) DE69000467T2 (fi)
DK (1) DK0380217T3 (fi)
EG (1) EG19306A (fi)
ES (1) ES2053094T3 (fi)
FI (1) FI95381C (fi)
GR (1) GR3006925T3 (fi)
HU (1) HU215154B (fi)
IE (1) IE62670B1 (fi)
IL (1) IL93073A (fi)
IS (1) IS1667B (fi)
MA (1) MA21735A1 (fi)
MX (1) MX19222A (fi)
MY (1) MY104861A (fi)
NO (1) NO175978C (fi)
NZ (1) NZ232168A (fi)
OA (1) OA10041A (fi)
PL (1) PL163836B1 (fi)
PT (1) PT92919B (fi)
RO (1) RO110142B1 (fi)
RU (1) RU2015977C1 (fi)
SK (1) SK279339B6 (fi)
WO (2) WO1990008148A1 (fi)
YU (1) YU47554B (fi)
ZA (1) ZA90430B (fi)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990008148A1 (en) * 1989-01-23 1990-07-26 Pfizer Inc. Bis-aza-bicyclic anxiolytic agents
WO1992000075A1 (en) * 1990-06-29 1992-01-09 Pfizer Inc. Pyridopyrazine derivatives for treating substance abuse and addiction
EP0569387B1 (en) * 1991-01-31 1995-04-05 Pfizer Inc. Resolution of trans-2-(2-pyrimidinyl)-7-(hydroxymethyl)octahydro-2h-pyrido 1,2-a]pyrazine
US5157034A (en) * 1991-02-27 1992-10-20 Pfizer Inc. Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines
CA2101252C (en) * 1991-02-27 1998-02-17 Frank J. Urban Process for preparing trans-piperidine-2,5- dicarboxylates
US5185449A (en) * 1991-02-27 1993-02-09 Pfizer Inc. Process and intermediate for certain bis-aza-bicyclic anxiolytic agents
US5311195A (en) * 1991-08-30 1994-05-10 Etak, Inc. Combined relative and absolute positioning method and apparatus
US5565453A (en) * 1991-09-25 1996-10-15 Pfizer Inc. Neuroleptic 2-substituted perhydro-1-h-pyrido[1,2-a]pyrazines
US5719286A (en) * 1992-06-16 1998-02-17 Pfizer Inc. Process and intermediates for bis-aza-bicyclic anxiolytic agents
WO1994006794A1 (en) * 1992-09-24 1994-03-31 National Institutes Of Health Aralkyl diazabicycloalkane derivatives for cns disorders
IL104506A (en) * 1993-01-25 1997-11-20 Israel State Fast changing heating- cooling device and method, particularly for cryogenic and/or surgical use
US5637713A (en) * 1993-08-20 1997-06-10 Pfizer Inc. Process for preparing trans-piperidine-2,5-dicarboxylates
US5455350A (en) * 1993-10-13 1995-10-03 Pfizer Inc. Process and intermediate for certain bis-aza-bicyclic anxiolytic agents
IL107460A (en) * 1993-11-01 1999-06-20 Israel State Controlled cryogenic contact system
US6231833B1 (en) 1999-08-05 2001-05-15 Pfizer Inc 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
WO1996010571A1 (en) * 1994-09-30 1996-04-11 Pfizer Inc. 2,7-SUBSTITUTED OCTAHYDRO-1H-PYRIDO[1,2-a]PYRAZINE DERIVATIVES
WO1996010570A1 (en) * 1994-09-30 1996-04-11 Pfizer Inc. NEUROLEPTIC 2,7-DISUBSTITUTED PERHYDRO-1H-PYRIDO[1,2-a]PYRAZINES
DE69615404T2 (de) * 1995-12-21 2002-06-06 Pfizer 2,7-SUBSTITUIERTE OCTAHYDROPYRROLO(1,2-a)PYRAZINDERIVATE
CA2259496A1 (en) * 1996-07-01 1998-01-08 Philip Dietrich Hammen Preparation of (7s,trans)-2-(2-pyrimidinyl)-7-(hydroxymethyl)octahydro-2h-pyrido[1,2-a]pyrazine
PA8469101A1 (es) * 1998-04-09 2000-09-29 Pfizer Prod Inc Ligandos azabiciclicos de receptores 5ht1
US6251893B1 (en) * 1998-06-15 2001-06-26 Nps Allelix Corp. Bicyclic piperidine and piperazine compounds having 5-HT6 receptor affinity
HN1999000146A (es) * 1998-09-21 2000-11-11 Pfizer Prod Inc Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas.
US20020016334A1 (en) * 2000-07-31 2002-02-07 Coe Jotham Wadsworth Pharmaceutical composition for the treatment of attention deficit hyperactivity disorder (ADHD)
US6670476B2 (en) 2000-11-29 2003-12-30 Pfizer Inc. Resolution of trans-7-(hydroxy-methyl)octa-hydro-2H-pyrido[1,2-a]pyrazine
JP3910627B2 (ja) * 2003-03-12 2007-04-25 ファイザー・プロダクツ・インク ピリジルオキシメチルおよびベンゾイソオキサゾールのアザビシクロ環の誘導体
US7834014B2 (en) 2003-04-09 2010-11-16 Biogen Idec Ma Inc. A2a adenosine receptor antagonists
ES2347152T3 (es) * 2003-11-26 2010-10-26 Pfizer Products Inc. Derivados de aminopirazol como inhibidores de gsk-3.
US20070219201A1 (en) * 2004-05-27 2007-09-20 Warner-Lambert Company Llc Combination of atomoxetine and a 5ht1a receptor agonist for treating adhd and other disorders
US7658206B2 (en) 2006-12-05 2010-02-09 Kohler Co. Plumbing valve with stick control handle

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3388128A (en) * 1965-09-03 1968-06-11 Allan R. Day Substituted 1, 4-diazabicyclo [4. 4. 9] decanes
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
US4339579A (en) * 1980-12-29 1982-07-13 American Home Products Corporation 2,6-Bis-(pyrrolopyrazinyl)pyrazines
US4400511A (en) * 1982-05-07 1983-08-23 American Home Products Corporation 2-Substituted octahydropyrrolo(1,2-A)-pyrazine-3-carboxylic acids
US4414389A (en) * 1982-05-25 1983-11-08 American Home Products Corporation 4-Substituted-piperidino carboxamides
US4517187A (en) * 1982-10-18 1985-05-14 Pennwalt Corporation 1,3,4,6,7-11b-Hexahydro-7-phenyl-2H-pyrazino[2,1-a]isoquinolines methods of preparation, and use as antidepressants
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE3409440A1 (de) * 1984-03-15 1985-09-26 Bayer Ag, 5090 Leverkusen Imidazo(1,5-a)pyridyl-methan- und imidazo(1,5-b)pyridazinylmethan-derivate, ihre herstellung und sie enthaltende aufzeichnungsmaterialien
IT1204803B (it) * 1986-02-17 1989-03-10 Acraf Composto farmacologicamente attivo e composizioni farmaceutiche che lo contengono,procedimento per prepararlo e intermedio utile in detto procedimento
US4788290A (en) * 1987-12-11 1988-11-29 American Home Products Corporation Serotonergic pyrazine derivatives
JP2668259B2 (ja) * 1988-02-18 1997-10-27 塩野義製薬株式会社 複素環化合物および抗潰瘍剤
WO1990008148A1 (en) * 1989-01-23 1990-07-26 Pfizer Inc. Bis-aza-bicyclic anxiolytic agents

Also Published As

Publication number Publication date
CA2008108A1 (en) 1990-07-23
BA98302A (bs) 2001-09-14
US5122525A (en) 1992-06-16
FI95381C (fi) 1996-01-25
BG51046A3 (en) 1993-01-15
OA10041A (en) 1996-10-14
PT92919A (pt) 1990-07-31
ZA90430B (en) 1991-08-28
GR3006925T3 (fi) 1993-06-30
EP0380217B1 (en) 1992-11-19
ATE82574T1 (de) 1992-12-15
KR900011774A (ko) 1990-08-02
IS3529A7 (is) 1990-07-24
MA21735A1 (fr) 1990-10-01
CN1022186C (zh) 1993-09-22
MX19222A (es) 1993-12-01
IE62670B1 (en) 1995-03-08
AU4867990A (en) 1990-07-26
RO110142B1 (ro) 1995-10-30
KR910009289B1 (ko) 1991-11-09
RU2015977C1 (ru) 1994-07-15
YU47554B (sh) 1995-10-03
CA2008108C (en) 1995-08-08
EG19306A (en) 1995-01-31
EP0380217A1 (en) 1990-08-01
MY104861A (en) 1994-06-30
HUT63163A (en) 1993-07-28
JPH0643427B2 (ja) 1994-06-08
IL93073A (en) 1994-05-30
WO1990008148A1 (en) 1990-07-26
CS29990A3 (en) 1992-11-18
DE69000467T2 (de) 1993-04-01
HU215154B (hu) 2000-09-28
AU614214B2 (en) 1991-08-22
YU11190A (sh) 1993-05-28
NO912863D0 (no) 1991-07-22
AP128A (en) 1991-03-20
PL163836B1 (pl) 1994-05-31
FI95381B (fi) 1995-10-13
WO1990008144A1 (en) 1990-07-26
DE69000467D1 (de) 1992-12-24
IE900225L (en) 1990-07-23
DK0380217T3 (da) 1992-12-14
SK279339B6 (sk) 1998-10-07
CZ277698B6 (en) 1993-03-17
AP9000158A0 (en) 1990-01-31
CN1044464A (zh) 1990-08-08
NO175978B (no) 1994-10-03
NZ232168A (en) 1991-08-27
IS1667B (is) 1997-11-14
NO912863L (no) 1991-07-22
AR246969A1 (es) 1994-10-31
NO175978C (no) 1995-01-11
PT92919B (pt) 1995-12-29
JPH02233681A (ja) 1990-09-17
DD291560A5 (de) 1991-07-04
ES2053094T3 (es) 1994-07-16

Similar Documents

Publication Publication Date Title
FI913510A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten, raseemisten tai optisesti aktiivisten pyrido/1,2-a/pyratsiinien valmistamiseksi
NO175531C (no) Analogifremgangsmåte til fremstilling av terapeutisk aktive imidazo(4,5-b)-kinolinyloksyalkansyreamider
NO179584C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler
FI890282A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
HU908147D0 (en) Process for the production of n-(pyrrolo/2,3-d/pyrimidine-3-yl-acyl)-glutamine-acid derivatives
PT86687A (pt) Process for the preparation of novel polyamine derivatives
FI880467A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
NO177096C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte isokinoliner
FI900897A0 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 4,5,6,7-tetrahydroimidatso/4,5,1-jk//1,4/bentsodiatsepiini-2(1H)-tionijohdannaisten valmistamiseksi
NO175976C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(1,6-dihydro-6-okso-pyridazinyl-3-oksy)-3-kromanolderivater
FI891004A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 4-substituoitujen pyratsolo/3,4-d/pyrimidiinijohdannaisten valmistamiseksi
FI892684A (fi) Menetelmä terapeuttisesti aktiivisten 4-okso-imidatso/1,5-a/kinoksaliinijohdannaisten valmistamiseksi
NO174203C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive
NO174774C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive benzodiazepiner
FI911701A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-substituoitujen alkyyli-3-karboksikarbapeneemien valmistamiseksi
PT88432A (pt) Process for the preparation of 4-oxo-3-quinolinecarboxylic acids useful as antibacterial agents
PT88431A (pt) Process for the preparation of 4-oxo-3-quinolinecarboxylic acids useful as antibacterial agents
FI93216C (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi
FI93725B (fi) Menetelmä optisesti aktiivisten, oikealle kiertävien okso-isoindolinyylijohdannaisten valmistamiseksi
FI910448A (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,2,3,3a,8,8a-heksahydro-1,3a,8-trimetyylipyrrolo/2,3b/indolijohdannaisten valmistamiseksi
NO175780C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte dibenzofuraner
NO178375C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive NMDA-antagonister
NO174393C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 6-metyl-19-nor-pregna-4,6-diener som er 17 eventuelt 21-alkylert
FI882836A (fi) Menetelmä terapeuttisesti käyttökelpoisen (E)-2-(p-fluorifenetyyli)-3-fluoriallyyliamiinin valmistamiseksi
FI921070A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 4,5,6,7-tetrahydroimidatso [4,5,1-jk][1,4]bentsodiatsepin-2-oni ja -2-tionijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
MA Patent expired